Feder Julie B
- SEC CIK
- 0001710237
No open-market purchases or sales filed in the past year.
Current role at each company
- AURA Aura Biosciences, Inc.Chief Financial Officeras of Oct 21, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Feder Julie B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 (view filing) | Oct 18 | 3 days | Feder Julie BChief Financial Officer | SSale | −25.1K | $12.03 | −$302.3K | −15.8%134.3K after | 10b5-1 |
| Jan 24, 2024 (view filing) | Jan 23 | 1 day | Feder Julie BChief Financial Officer | SSale | −6.61K | $7.64 | −$50.5K | −9.5%63.0K after | |
| Nov 7, 2023 (view filing) | Nov 6 | 1 day | Feder Julie BChief Financial Officer | SSale | −3.90K | $12.07 | −$47.1K | −5.3%69.6K after | 10b5-1 |
| Nov 1, 2023 (view filing) | Oct 30 | 2 days | Feder Julie BChief Financial Officer | SSale | −3.38K | $6.82 | −$23.1K | −4.6%69.6K after | |
| Nov 2, 2022 (view filing) | Oct 31 | 2 days | Feder Julie BChief Financial Officer | SSale | −2.02K | $12.45 | −$25.1K | −7.7%24.2K after |